New Key Statistics Module, Z-Score and F-Score
NAS:TBPH Key Ratios
Market Cap $ M | 422.69 |
Enterprise Value $ M | 372.78 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 139.35 |
Price/Book | 2.18 |
Price/Sales | 6.92 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 62.00 |
EPS (TTM) $ | -0.92 |
Beneish M-Score | -2.9 |
10-y EBITDA Growth Rate % | 14.90 |
5-y EBITDA Growth Rate % | 29.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.44 |
EV-to-EBITDA | -11.95 |
PEG | -- |
Shares Outstanding M | 48.92 |
Net Margin (%) | -73.61 |
Operating Margin % | -62.82 |
Pre-tax Margin (%) | -61.63 |
Quick Ratio | 5.20 |
Current Ratio | 5.20 |
ROA % (ttm) | -11.55 |
ROE % (ttm) | -20.06 |
ROIC % (ttm) | -18.07 |
Dividend Yield % | -- |
Altman Z-Score | -1.95 |
TBPH Number of Guru Trades
TBPH Volume of Guru Trades
Gurus Latest Trades with NAS:TBPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TBPH is held by these investors
Total 1
Theravance Biopharma Inc Insider Transactions
No Available Data
News about NAS:TBPH
Total 0- 1